跳至主要内容
临床试验/NCT05880069
NCT05880069Enrolling By Invitation不适用

Clinical Outcomes in Patients With Infection by Resistant Microorganism

Hospital Universitario Virgen Macarena1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2022年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
5,000
试验地点
1
主要终点
Mortality

研究概览

简要总结

The goal of this individual patient data meta-analysis is to estimate the attributed and the associated health burden related to bloodstream infections, pneumonia, skin and soft tissue infections, surgical site infections and urinary tract infections, caused by target drug-resistant pathogens, in high income countries.

The main question[s] it aims to answer are:

  • Are common infections caused by drug-resistant pathogens associated with an increased health burden, when compared with individuals with the same infection caused by a susceptible strain (attributed burden)?
  • Are common infections caused by drug-resistant pathogens associated with an increase health burden, when compared with individuals without the infection under study (associated burden)?

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Individuals of all ages
  • Individuals with hospital acquired, community acquired, or healthcare associated infections
  • Individuals treated at hospital level, community, or long-term care facilities
  • Individuals with the targeted pathogen, resistance phenotype, and infection site combinations under study

排除标准

  • Individuals with infections in the following systems: central nervous system, genital system, pelvic infections and head and neck infections
  • Individuals with the following specific primary infections: endocarditis, upper respiratory tract infections, lung abscess
  • Individuals with bacterial infections not included in the table of pathogens of interest, polymicrobial infections except for intraabdominal infections, fungal infections, parasitic infections, viral infections, mycobacterial infections, sexually transmitted diseases, and zoonotic infections

结局指标

主要结局

Mortality

时间窗: Through study completion, an average of 1 year

Death any time after infection, during the follow-up time of the original study.

次要结局

  • Number of participants with ICU admission(Through study completion, an average of 1 year)
  • Number of participants with recurrence of infection(Through study completion, an average of 1 year)
  • Number of participants with cognitive impairment / disability(Through study completion, an average of 1 year)
  • Number of participants with superinfection(Through study completion, an average of 1 year)
  • Number of participants with clinical cure(Through study completion, an average of 1 year)
  • Number of participants with microbiological cure(Through study completion, an average of 1 year)

研究者

发起方
Hospital Universitario Virgen Macarena
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验